PT UBC Medical Indonesia Tbk (ISX:LABS) EV-to-EBITDA: (As of Sep. 10, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:LABS PT UBC Medical Indonesia Tbk ISX:LABS
2 GF Score
Price Rp177.00
! 2 Warning Signs
View Full Analysis

What is PT UBC Medical Indonesia Tbk EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, PT UBC Medical Indonesia Tbk's enterprise value is Rp699,150.00 Mil. PT UBC Medical Indonesia Tbk does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate PT UBC Medical Indonesia Tbk's EV-to-EBITDA at this moment.

The historical rank and industry rank for PT UBC Medical Indonesia Tbk's EV-to-EBITDA or its related term are showing as below:

ISX:LABS's EV-to-EBITDA is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 13.965
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2026-09-10), PT UBC Medical Indonesia Tbk's stock price is Rp177.00. PT UBC Medical Indonesia Tbk does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate PT UBC Medical Indonesia Tbk's PE Ratio (TTM) at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).

PT UBC Medical Indonesia Tbk  (ISX:LABS) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

PT UBC Medical Indonesia Tbk's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=177.00/
=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

PT UBC Medical Indonesia Tbk EV-to-EBITDA Related Terms

PT UBC Medical Indonesia Tbk EV-to-EBITDA Historical Data

* Premium members only.

The historical data trend for PT UBC Medical Indonesia Tbk's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT UBC Medical Indonesia Tbk EV-to-EBITDA Chart

PT UBC Medical Indonesia Tbk Annual Data
Trend
EV-to-EBITDA

PT UBC Medical Indonesia Tbk Semi-Annual Data
EV-to-EBITDA

ISX:LABS vs ABT, SYK, MDT: EV-to-EBITDA Comparison

For the Medical Devices subindustry, PT UBC Medical Indonesia Tbk's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT UBC Medical Indonesia Tbk EV-to-EBITDA vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PT UBC Medical Indonesia Tbk's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where PT UBC Medical Indonesia Tbk's EV-to-EBITDA falls into.


ISX:LABS
2GF Score
PT UBC Medical Indonesia Tbk ISX:LABS
EV-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT UBC Medical Indonesia Tbk EV-to-EBITDA Calculation

PT UBC Medical Indonesia Tbk's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=699150.000/
=

PT UBC Medical Indonesia Tbk Business Description

Address Jl. Rawagelam V, Blok L, No Kav 11-13, Kantor Pusat, Kawasan Industri Pulogadung, Kel. Jatinegara Kec. Cakung, Jakarta Timur, Jakarta, IDN
PT UBC Medical Indonesia Tbk is a distribution company. It engages in wholesale of Laboratory Equipment, Pharmaceutical Equipment, and Medical Equipment for Humans and animals, which includes the wholesale of laboratory equipment, pharmaceutical equipment, and medical equipment. It divides its main marketed medical equipment products into two categories Instruments, in the form of equipment, machines, and analyzers, are used in laboratories. The function of instruments is to process specimens or biological samples to measure and examine the levels of certain substances/contents; and Consumables include single-use medical devices used for treatment or health examinations and Reagents include chemical reagents used in laboratory tests to detect, measure, examine, & produce other substances.
2GF Score

Get the complete analysis for ISX:LABS

EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp177.00
Price